Literature DB >> 9972681

Is thyroxine during lithium therapy necessary?

J H Lazarus1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9972681     DOI: 10.1007/BF03348047

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  10 in total

1.  Granulomatous thyroiditis and lithium therapy.

Authors:  M J Sinnott; H D McIntyre; S M Pond
Journal:  Aust N Z J Med       Date:  1992-02

2.  Occurrence of goitre during lithium treatment.

Authors:  M Schou; A Amdisen; S Eskjaer Jensen; T Olsen
Journal:  Br Med J       Date:  1968-09-21

3.  Thyrotoxicosis developing during lithium treatment: case report.

Authors:  L M Franklin
Journal:  N Z Med J       Date:  1974-03-27

4.  The effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements.

Authors:  M H Rapaport; M E Schmidt; R Risinger; H Manji
Journal:  Biol Psychiatry       Date:  1994-05-15       Impact factor: 13.382

5.  Hormone therapy in depressive diseases.

Authors:  A J Prange; P T Loosen
Journal:  Adv Biochem Psychopharmacol       Date:  1982

6.  Sex related goitrogenic effect of lithium carbonate in healthy young subjects.

Authors:  H Perrild; L Hegedüs; K Arnung
Journal:  Acta Endocrinol (Copenh)       Date:  1984-06

7.  [Humoral autoimmune phenomena during long-term lithium treatment with special reference to thyroid autoantibodies].

Authors:  J Albrecht; U Hopf
Journal:  Klin Wochenschr       Date:  1982-12-15

8.  Prevalence of antithyroid antibodies in mood disorders.

Authors:  J J Haggerty; S G Silva; M Marquardt; G A Mason; H Y Chang; D L Evans; R N Golden; C Pedersen
Journal:  Depress Anxiety       Date:  1997       Impact factor: 6.505

9.  Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence.

Authors:  M L Barclay; B E Brownlie; J G Turner; J E Wells
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

10.  The course of thyroid abnormalities during lithium treatment: a two-year follow-up study.

Authors:  A Bocchetta; F Bernardi; C Burrai; M Pedditzi; A Loviselli; F Velluzzi; E Martino; M Del Zompo
Journal:  Acta Psychiatr Scand       Date:  1992-07       Impact factor: 6.392

  10 in total
  5 in total

1.  About thyroxine administration during lithium therapy.

Authors:  N Panza; B Biondi; C Carella; G Lombardi
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

Review 2.  Is thyroxine during lithium therapy necessary?

Authors:  L Bartalena; F Bogazzi; E Martino
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

Review 3.  Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?

Authors:  F Bogazzi; E Martino; L Bartalena
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

4.  Fifteen-year follow-up of thyroid function in lithium patients.

Authors:  A Bocchetta; F Cocco; F Velluzzi; M Del Zompo; S Mariotti; A Loviselli
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

5.  Lithium treatment and thyroid abnormalities.

Authors:  Alberto Bocchetta; Andrea Loviselli
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.